Cite
MLA Citation
Marc Bourlière et al.. “Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).” Lancet infectious diseases, vol. 15, no. 4, n.d., pp. 397–404. http://access.bl.uk/ark:/81055/vdc_100051427177.0x000013